Induction of Fas ligand in murine bone marrow NK cells by bacterial polysaccharides

Journal of Immunology

Volumn 160, Issue 9, 1998, Pages 4330-4336

  Halaas, Øyvind ^a   Vik, Randi ^a   Espevik, Terje ^a  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL POLYSACCHARIDE; CD11B ANTIGEN; CD2 ANTIGEN; CD32 ANTIGEN; CD4 ANTIGEN; CD45 ANTIGEN; CD8 ANTIGEN; CYTOKINE; FAS LIGAND; HYBRID PROTEIN; MESSENGER RNA;

ANIMAL CELL; ARTICLE; BONE MARROW; CONTROLLED STUDY; CYTOTOXICITY; DOSE RESPONSE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; BONE MARROW CELLS; CELLS, CULTURED; CYTOTOXICITY, IMMUNOLOGIC; FAS LIGAND PROTEIN; KILLER CELLS, NATURAL; LIPOPOLYSACCHARIDES; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; POLYSACCHARIDES, BACTERIAL; PSEUDOMONAS AERUGINOSA;

EID: 0032080606     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Morrison, D., and J. Ulevitch. 1978. The effects of bacterial endotoxins on host mediation systems: a review. Am. J. Pathol. 93:525.
2. Bone, R. C. 1991. The pathogenesis of sepsis. Ann. Intern. Med. 115:457.
3. Ayala, A., C. D. Herdon, D. L. Lehman, C. A. Ayala, and I. H. Chaudry. 1996. Differential induction of apoptosis in lymphoid tissues during sepsis: variation in onset, frequency, and the nature of the mediators. Blood 87:4261.
4. Zhang, X. M., A. Morikawa, K. Takahashi, G. Z. Jiang, Y. Kato, T. Sugiyama, M. Kawai, M. Fukada, and T. Yokochi. 1994. Localization of apoptosis (programmed cell death) in mice by administration of lipopolysaccharide. Microbiol. Immunol. 38:669.
5. Haendeler, J., U. K. Meßmer, B. Brüne, E. Neugebauer, and S. Dimmeler. 1996. Endotoxic shock leads to apoptosis in vivo and reduces Bc1-2. Shock 6:405.
6. Buchman, T. G., P. A. Abello, E. H. Smith, and G. B. Bulkley. 1993. Induction of heat shock response leads to apoptosis in endothelial cells previously exposed to endotoxin. Am. J. Physiol. 265:H165.
7. Colotta, F., F. Re, N. Polentarutti, S. Sozzani, and A. Mantovani. 1992. Modulation of granulocyte survival and programmed cell death by cytokines and bacterial products. Blood 80:2012.
8. Mangan, D. F., G. R. Welch, and S. M. Wahl. 1991. Lipopolysaccharide, tumor necrosis factor-α, and IL-1 β prevent programmed cell death (apoptosis) in human peripheral blood monocytes. J. Immunol. 146:1541.
9. Kiener, P. A., P. M. Davis, G. C. Starling, C. Mehlin, S. J. Klebanoff, J. A. Ledbetter, and W. C. Liles. 1997. Differential induction of apoptosis by Fas-Fas ligand interactions in human monocytes and macrophages. J. Exp. Med. 185:1511.
10. Iwai, K., T. Miyawaki, T. Takizawa, A. Konno, K. Ohta, A. Yachie, H. Seki, and N. Taniguchi. 1994. Differential expression of bcl-2 and susceptibility to anti-Fas-mediated cell death in peripheral blood lymphocytes, monocytes, and neutrophils. Blood 84:1201.
11. Liles, W. C., P. A. Kiener, J. A. Ledbetter, A. Aruffo, and S. J. Klebanoff. 1996. Differential expression of Fas (CD95) and Fas ligand on normal human phagocytes: implications for the regulation of apoptosis in neutrophils. J. Exp. Med. 184:429.
12. Nagata, S., and P. Golstein. 1995. The Fas death factor. Science 267:1449.
13. Medvedev, A. E., A.-C. Johnsen, J. Haux, B. Steinkjer, K. Egeberg, D. H. Lynch, A. Sundan, and T. Espevik. 1997. Regulation of Fas and Fas-ligand expression in NK cells by cytokines and the involvement of Fas-ligand in NK/LAK cell-mediated cytotoxicity. Cytokine 9:394.
14. + human marrow cells is induced by interferon γ and tumor necrosis factor α and potentiates cytokine-mediated hematopoietic suppression in vitro. Blood 85:3183.
15. Nagafuji, K., T. Shibuya, M. Harada, S. Mizuno, K. Takenaka, T. Miyamoto, T. Okamura, H. Gondo, and Y. Niho. 1995. Functional expression of Fas antigen (CD95) on hematopoietic progenitor cells. Blood 86:883.
16. Barcena, A., S. W. Park, B. Banapour, M. O. Muench, and E. Mechetner. 1996. Expression of Fas/CD95 and Bcl-2 by primitive hematopoietic progenitors freshly isolated from human fetal liver. Blood 88:2013.
17. Alderson, M. R., R. J. Armitage, E. Maraskovsky, T. W. Tough, E. Roux, K. Schooley, F. Ramsdell, and D. H. Lynch. 1993. Fas transduces activation signals in normal human T lymphocytes. J. Exp. Med. 178:2231.
18. Suda, T., T. Okazaki, Y. Naito, T. Yokota, N. Arai, S. Ozaki, K. Nakao, and S. Nagata. 1995. Expression of the Fas ligand in cells of T cell lineage. J. Immunol. 154:3806.
19. Hahne, M., T. Renno, M. Schroeter, M. Irmler, L. French, T. Bornard, H. R. MacDonald, and J. Tschopp. 1996. Activated B cells express functional Fas ligand. Eur. J. Immunol. 26:721.
20. Arase, H., N. Arase, and T. Saito. 1995. Fas-mediated cytotoxicity by freshly isolated natural killer cells. J. Exp. Med. 181:1235.
21. French, L. E., M. Hahne, I. Viard, G. Radlgruber, R. Zanone, K. Becker, C. Muller, and J. Tschopp. 1996. Fas and Fas ligand in embryos and adult mice: ligand expression in several immune-privileged tissues and coexpression in adult tissues characterized by apoptotic cell turnover. J. Cell Biol. 133:335.
22. Otterlei, M., A. Sundan, G. Skjåk-Bræk. L. Ryan, O. Smidsrød, and T. Espevik. 1993. Similar mechanisms of action of denned polysaccharides and lipopolysaccharides: characterization of binding and tumor necrosis factor α induction. Infect. Immun. 61:1917.
23. Otterlei, M., K. Østgaard, G. Skjåk-Bræk, O. Smidsrød, P. Soon Shiong, and T. Espevik. 1991. Induction of cytokine production from human monocytes stimulated with alginate. J. Immunother. 10:286.
24. Espevik, T., M. Otterlei, G. Skjåk-Bræk, L. Ryan, S. D. Wright, and A. Sundan. 1993. The involvement of CD14 in stimulation of cytokine production by uronic acid polymers. Eur. J. Immunol. 23:255.
25. Jahr, T. G., L. Ryan, A. Sundan, H. S. Lichenstein, G. Skjåk-Bræk, and T. Espevik. 1997. Induction of tumor necrosis factor production from monocytes stimulated with mannuronic acid polymers and involvement of lipopolysaccharide-binding protein, CD14, and bactericidal/permeability-increasing factor. Infect. Immun. 65:89.
26. Skaugrud, Ø., J. E. Melvik, M. Dornish, G. Skjåk-Bræk, and T. Espevik. 1997. Prophylaxis of LPS-or pathogen-induced sepsis with poly mannuronic acid (poly M). In IBC's Seventh Annual International Conference on Sepsis (Abstr.).
27. Halaas, Ø., W. M. Olsen, O. P. Veiby, D. Levhaug, G. Skjåk-Bræk, R. Vik, and T. Espevik. 1997. Mannuronan enhances survival of lethally irradiated mice and stimulates murine haematopoiesis in vitro. Scand. J. Immunol. 46:358.
28. Hahne, M., M. C. Peitsch, M. Irmler, M. Schroter, B. Lowin, M. Rousseau, C. Bron, T. Renno, L. French, and J. Tschopp. 1995. Characterization of the non-functional Fas ligand of gld mice. Int. Immunol. 7:1381.
29. Rouvier, E., M. F. Luciani, and P. Golstein. 1993. Fas involvement in Ca(2+)-independent T cell-mediated cytotoxicity. J. Exp. Med. 177:195.
30. Kägi, D., F. Vignaux, B. Ledermann, K. Burki, V. Depraetere, S. Nagata, H. Hengartner, and P. Golstein. 1994. Fas and perform pathways as major mechanisms of T cell-mediated cytotoxicity. Science 265:528.
31. Stanley, E. R. 1985. The macrophage colony-stimulating factor, CSF-1. Methods Enzymol. 116:564.
32. Mosmann, T. 1983. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods. 65:55.
33. Espevik, T., and J. Nissen Meyer. 1986. A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes. J. Immunol. Methods 95:99.
34. 3 U/ml of interleukin-2. J. Immunol. Methods 99:7.
35. Mosmann, T. R., H. Cherwinski, M. W. Bond, M. A. Giedlin, and R. L. Coffman. 1986. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 136:2348.
36. Aarden, L. A., E. R. De Groot, O. L. Schaap, and P. M. Lansdorp. 1987. Production of hybridoma growth factor by human monocytes. Eur. J. Immunol. 17:1411.
37. Yang, Y., M. Mercep, C. F. Ware, and J. D. Ashwell. 1995. Fas and activation-induced Fas ligand mediate apoptosis of T cell hybridomas: inhibition of Fas ligand expression by retinoic acid and glucocorticoids. J. Exp. Med. 181:1673.
38. Vaillier, D., R. Daculsi, and N. Gualde. 1992. Effects of lipopolysaccharide on interleukin-2-induced cytotoxic activity of murine splenocyte cultures: role of prostaglandin E2 and interferons. Cancer Immunol. Immunother. 35:395.
39. Griffin, J. D., T. Hercend, R. Beveridge, and S. F. Schlossman. 1983. Characterization of an antigen expressed by human natural killer cells. J. Immunol. 130:2947.
40. Chaby, R., and R. Girard. 1993. Interaction of lipopolysaccharides with cells of immunological interest. Eur. Cytokine Netw. 4:399.
41. Carson, W. E., J. G. Giri, M. J. Lindemann, M. L. Linett, M. Ahdieh, R. Paxton, D. Anderson, J. Eisenmann, K. Grabstein, and M. A. Caligiuri. 1994. Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor. J. Exp. Med. 180:1395.
42. Tsutsui, H., K. Nakanishi, K. Matsui, K. Hagashino, H. Okamura, Y. Miyazawa, and K. Kaneda. 1996. IFN-gamma-inducing factor up-regulates Fas ligand-mediated cytotoxic activity of murine natural killer cell clones. J. Immunol. 157: 3967.
43. Baker, M. B., R. L. Riley, E. R. Podack, and R. B. Levy. 1997. Graft-versus-host disease-associated lymphoid hypoplasia and B cell dysfunction is dependent upon donor T cell-mediated Fas-ligand function, but not perform function. Proc. Natl. Acad. Sci. USA 94:1366.
44. Okura, T., L. Gong, T. Kamitani, T. Wada, I. Okura, C. F. Wei, H. M. Chang, and E. T. Yeh. 1996. Protection against Fas/APO-1- and tumor necrosis factor-mediated cell death by a novel protein, sentrin. J. Immunol. 157:4277.
45. Sato, T., S. Irie, S. Kitada, and J. C. Reed. 1995. FAP-1: a protein tyrosine phosphatase that associates with Fas. Science 268:411.
46. Nestel, F. P., K. S. Price, T. A. Seemayer, and W. S. Lapp. 1992. Macrophage priming and lipopolysaccharide-triggered release of tumor necrosis factor α during graft-versus-host disease. J. Exp. Med. 175:405.
47. MacDonald, G. C., and J. G. Gartner. 1992. Prevention of acute lethal graft-versus-host disease in F1 hybrid mice by pretreatment of the graft with anti-NK1.1 and complement. Transplantation 54:147.